European Case Law Identifier: | ECLI:EP:BA:2011:T060610.20110512 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 12 May 2011 | ||||||||
Case number: | T 0606/10 | ||||||||
Application number: | 92201711.6 | ||||||||
IPC class: | C12N 15/10 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome | ||||||||
Applicant name: | Novartis Vaccines and Diagnostics, Inc. | ||||||||
Opponent name: | Institut Pasteur | ||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Respondent's main request - termination of the appeal proceedings (no) Common request of appellant and respondent - patent to be revoked (yes) |
||||||||
Catchwords: |
see points 1.1 to 1.8 of the Reasons |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t100606eu1.html
Date retrieved: 17 May 2021
12 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
EPC Implementing Rules
XR.84 EPC Continuation of the opposition proceedings by the European Patent Office of its own motion